Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
Prakash Jagtap, Csaba Szabo
Research output
:
Contribution to journal
›
Review article
›
peer-review
718
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Therapeutic Effect
100%
Poly(ADP-ribose) Polymerase
100%
PARP Inhibitor (PARPi)
60%
Cell Necrosis
40%
DNA Damage
20%
DNA Repair
20%
Therapeutic Action
20%
Cytotoxicity
20%
Inflammation Injury
20%
Inflammatory Genes
20%
Tissue Injury
20%
Diabetes Complications
20%
Cell Behavior
20%
Drug Development
20%
Cellular Energetics
20%
Myocardial Infarction
20%
Anticancer Drugs
20%
Human Clinical Trial
20%
Pharmacological Inhibitors
20%
Pathophysiological Mechanisms
20%
Colitis
20%
Circulatory Shock
20%
Cell Dysfunction
20%
Parenchymal Cells
20%
Pathophysiological Pathways
20%
INIS
polymerases
100%
adp
100%
ribose
100%
inflammation
28%
necrosis
28%
capacity
28%
humans
14%
dna
14%
genes
14%
drugs
14%
tissues
14%
injuries
14%
clinical trials
14%
toxicity
14%
dna repair
14%
regulations
14%
transcription
14%
pools
14%
myocardial infarction
14%
antineoplastic drugs
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Therapeutic Effect
100%
DNA
40%
Necrosis
40%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
40%
Inflammation
20%
Drug Development
20%
Clinical Trial
20%
Cytotoxicity
20%
Tissue Injury
20%
Anticarcinogen
20%
Shock
20%
Heart Infarction
20%
Diabetic Complication
20%
Colitis
20%
Medicine and Dentistry
PARP1
20%